• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肾移植和透析患者因 COVID-19 而死亡的风险仍然较高。

Kidney Transplant and Dialysis Patients Remain at Increased Risk for Succumbing to COVID-19.

机构信息

UNION therapeutics Research Services, Hellerup, Denmark.

Novo Nordisk Foundation Center for Biosustainability, Technical University Denmark, Kongens Lyngby, Denmark.

出版信息

Transplantation. 2023 May 1;107(5):1136-1138. doi: 10.1097/TP.0000000000004462. Epub 2023 Apr 22.

DOI:10.1097/TP.0000000000004462
PMID:36584380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10125010/
Abstract

BACKGROUND

Immunocompromised patients have been at an increased risk of succumbing to coronavirus disease 2019 (COVID-19) since the beginning of the pandemic.

METHODS

Here, we analyzed mortality and case fatality data from dialysis and kidney transplant patients, and compared each with an age-matched subgroup of the general population.

RESULTS

We found that both patients on dialysis and kidney transplant patients remain at increased risk of succumbing to COVID-19 despite all available countermeasures.

CONCLUSIONS

The analyses underline the need for additional protection for this vulnerable population.

摘要

背景

自疫情开始以来，免疫功能低下的患者罹患 2019 年冠状病毒病（COVID-19）的风险增加。

方法

在这里，我们分析了透析和肾移植患者的死亡率和病死率数据，并将其与一般人群的年龄匹配亚组进行了比较。

结果

我们发现，尽管采取了所有可用的对策，透析患者和肾移植患者仍有更高的 COVID-19 死亡风险。

结论

这些分析强调了为这一脆弱人群提供额外保护的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4198/10125109/5a2496d30f25/tpa-107-1136-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4198/10125109/5a2496d30f25/tpa-107-1136-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4198/10125109/5a2496d30f25/tpa-107-1136-g001.jpg

相似文献

1
Kidney Transplant and Dialysis Patients Remain at Increased Risk for Succumbing to COVID-19.肾移植和透析患者因 COVID-19 而死亡的风险仍然较高。
Transplantation. 2023 May 1;107(5):1136-1138. doi: 10.1097/TP.0000000000004462. Epub 2023 Apr 22.
2
Effect of the COVID-19 Pandemic on Kidney Transplant and on Chronic Dialysis Patients.COVID-19 大流行对肾移植和慢性透析患者的影响。
Transplant Proc. 2022 Jun;54(5):1282-1285. doi: 10.1016/j.transproceed.2022.02.061. Epub 2022 Apr 11.
3
Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.COVID-19 感染肾移植受者体内存在有效的体液免疫活性证据。
Am J Transplant. 2020 Nov;20(11):3149-3161. doi: 10.1111/ajt.16261. Epub 2020 Oct 2.
4
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration.COVID-19 相关死亡率在肾移植和透析患者：ERACODA 合作的结果。
Nephrol Dial Transplant. 2020 Nov 1;35(11):1973-1983. doi: 10.1093/ndt/gfaa261.
5
Do Lifestyle Changes of Renal Transplant Recipients During the Pandemic Reduce the Risk of Coronavirus Disease 2019?肾移植受者在疫情期间的生活方式改变是否能降低2019冠状病毒病的风险？
Transplant Proc. 2020 Nov;52(9):2667-2670. doi: 10.1016/j.transproceed.2020.07.003. Epub 2020 Jul 11.
6
Should Thorax Thin-Section Computed Tomography Be a Standard Diagnostic Procedure in the Evaluation of Potential Kidney Transplant Recipients? Lessons Learned From the COVID-19 Pandemic.在评估潜在肾移植受者时，是否应将胸部薄层 CT 作为标准诊断程序？从 COVID-19 大流行中吸取的教训。
Transplant Proc. 2022 May;54(4):890-896. doi: 10.1016/j.transproceed.2022.03.044. Epub 2022 Apr 22.
7
COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes.肾移植受者中的 COVID-19 感染：疾病发生率和临床结局。
J Am Soc Nephrol. 2020 Oct;31(10):2413-2423. doi: 10.1681/ASN.2020050639. Epub 2020 Aug 26.
8
The Impact of COVID-19 on Renal Resistive Index in Kidney Transplant Recipients.COVID-19 对肾移植受者肾阻力指数的影响。
Transplant Proc. 2023 Oct;55(8):1862-1865. doi: 10.1016/j.transproceed.2023.03.073. Epub 2023 Apr 6.
9
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.血液透析患者和肾移植受者队列中 SARS-CoV-2 mRNA 疫苗接种后的体液反应。
J Am Soc Nephrol. 2021 Sep;32(9):2153-2158. doi: 10.1681/ASN.2021040490. Epub 2021 Jun 16.
10
Low rate of COVID-19 pneumonia in kidney transplant recipients-A battle between infection and immune response?肾移植受者中新冠肺炎肺炎的低发病率——感染与免疫反应之间的较量？
Transpl Infect Dis. 2020 Oct;22(5):e13406. doi: 10.1111/tid.13406. Epub 2020 Jul 21.

引用本文的文献

1
The association between chronic underlying diseases and the clinical characteristics in adult patients infected with Omicron BA.1.成人感染奥密克戎BA.1毒株的慢性基础疾病与临床特征之间的关联
J Virus Erad. 2025 Mar 14;11(2):100591. doi: 10.1016/j.jve.2025.100591. eCollection 2025 Jun.
2
Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert Perspective.四类免疫功能低下人群中发生重症新型冠状病毒肺炎的风险：法国专家观点
Infect Dis Ther. 2025 Apr;14(4):671-733. doi: 10.1007/s40121-025-01124-3. Epub 2025 Mar 18.
3
Harnessing Social Media Data to Understand Information Needs About Kidney Diseases and Emotional Experiences With Disease Management: Topic and Sentiment Analysis.
利用社交媒体数据了解肾脏疾病的信息需求及疾病管理中的情感体验：主题与情感分析
J Med Internet Res. 2025 Feb 25;27:e64838. doi: 10.2196/64838.
4
Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V platform trial.COVID-19感染风险的肾病患者预防措施：PROTECT-V平台试验中鼻内使用氯硝柳胺随机、双盲、安慰剂对照组的结果。
BMC Infect Dis. 2025 Feb 11;25(1):204. doi: 10.1186/s12879-025-10584-4.
5
Antibody Response to SARS-CoV-2 Vaccines in Transplant Recipients and Hemodialysis Patients: Data from the Dominican Republic.移植受者和血液透析患者对SARS-CoV-2疫苗的抗体反应：来自多米尼加共和国的数据。
Vaccines (Basel). 2024 Nov 23;12(12):1312. doi: 10.3390/vaccines12121312.
6
Proteomic profiling of peripheral blood mononuclear cells reveals immune dysregulation and metabolic alterations in kidney transplant recipients with COVID-19.外周血单个核细胞的蛋白质组学分析揭示了新冠病毒肺炎肾移植受者的免疫失调和代谢改变。
Front Immunol. 2024 Dec 16;15:1508110. doi: 10.3389/fimmu.2024.1508110. eCollection 2024.
7
and Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients.肾移植受者中抗SARS-CoV-2变体单克隆抗体的中和效力
Transpl Int. 2024 Jul 16;37:13272. doi: 10.3389/ti.2024.13272. eCollection 2024.
8
Serological responses and clinical outcomes following a three-dose primary COVID-19 vaccine schedule in kidney transplant recipients and people on dialysis.肾移植受者和透析患者接种三剂新冠病毒病（COVID-19）初级疫苗后的血清学反应及临床结果
Clin Transl Immunology. 2024 Jul 25;13(7):e1523. doi: 10.1002/cti2.1523. eCollection 2024.
9
Comparison of COVID-19 Hospitalization and Death Between Solid Organ Transplant Recipients and the General Population in Canada, 2020-2022.2020 - 2022年加拿大实体器官移植受者与普通人群中新冠病毒疾病（COVID - 19）住院和死亡情况的比较
Transplant Direct. 2024 Jun 26;10(7):e1670. doi: 10.1097/TXD.0000000000001670. eCollection 2024 Jul.
10
Clinical characteristics and outcomes of hospitalized kidney transplant recipients with COVID-19 infection in China during the Omicron wave: a single-center cohort study.中国奥密克戎变异株流行期间住院肾移植受者 COVID-19 感染的临床特征和结局：一项单中心队列研究。
J Zhejiang Univ Sci B. 2024 Jun 15;25(6):529-540. doi: 10.1631/jzus.B2300538.